Citation: |
[1] |
J. Kendrew, "The Encyclopedia of Molecular Biology," Blackwell Science Ltd. Reprinted, 1995 |
[2] |
N. Trun and T. Trempy, "Fundamental Bacterial Genetics," Blackwell Publishing Company, 2004. |
[3] |
T. Ideker, T. Galitski and L. Hood, A new approach to decoding life: Systems biology, Annu Rev Genomics Hum Genet., 2 (2001), 343-372. |
[4] |
H. Kitano, Computational systems biology, Nature, 420 (2002), 206-210. |
[5] |
L. Hood, Systems biology: Integrating technology, biology, and computation, Mech Ageing Dev., 124 (2003), 9-16. |
[6] |
M. Cassman, Systems biology: International research and development, World Technology Evaluation Center. SpringerLink, Chapter I, (2007), 1-13. |
[7] |
F. J. Bruggeman and H. V. Westerhoff, The nature of systems biology, Trends Microbiol., 15 (2007), 45-50. |
[8] |
N. Barkai and S. Leibler, Robustness in simple biochemical networks, Nature, 387 (1997), 913-917. |
[9] |
B. N. Kholodenko, Cell-signalling dynamics in time and space, Nat. Rev. Mol. Cell Biol., 7 (2006), 165-176. |
[10] |
N. Borisov, E. Aksamitiene, A. Kiyatkin, S. Legewie, J. Berkhout, T. Maiwald, N. P. Kaimachnikov, J. Timmer, J. B. Hoek and B. N. Kholodenko, Systems-level interactions between insulin-EGF networks amplify mitogenic signaling, Mol Syst Biol., 5 (2009), 256. |
[11] |
L. Tortolina, N. Castagnino, C. De Ambrosi, E. Moran, F. Patrone, A. Ballestrero and S. Parodi, A multi-scale approach to colorectal cancer: From a biochemical-interaction signaling network level, to multi-cellular dynamics of malignant transformation. Interplay with mutations and onco-protein inhibitor drugs, Current Cancer Drug Target (CCDT), 12 (2012), 339-355. |
[12] |
D. Segré, D. Vitkup and G. M. Church, Analysis of optimality in natural and perturbed metabolic networks, Proc Natl Acad Sci U S A., 99 (2002), 15112-15117. |
[13] |
D. Segré, A. Deluna, G. M. Church and R. Kishony, Modular epistasis in yeast metabolism, Nat Genet., 37 (2005), 77-83. |
[14] |
W. Materi and D. S. Wishart, Computational systems biology in drug discovery and development: methods and applications, Drug Discov Today, 12 (2007), 295-303. |
[15] |
D. T. Gillespie, Exact stochastic simulation of coupled chemical reactions, J. Phys.Chem., 81 (1977), 2340-2361. |
[16] |
D. J. Wilkinson, Stochastic modelling for quantitative description of heterogeneous biological systems, Nat Rev Genet., 10 (2009), 122-33. |
[17] |
T. Sjöblom, S. Jones, L. D. Wood, D. W. Parsons, J. Lin, T. D. Barber, D. Mandelker, R. J. Leary, J. Ptak, N. Silliman, S. Szabo, P. Buckhaults, C. Farrell, P. Meeh, S. D. Markowitz, J. Willis, D. Dawson, J. K. Willson, A. F. Gazdar, J. Hartigan, L. Wu, C. Liu, G. Parmigiani, B. H. Park, K. E. Bachman, N. Papadopoulos, B. Vogelstein, K. W. Kinzler and V. E. Velculescu, The consensus coding sequences of human breast and colorectal cancers, Science, 314 (2006), 268-274. |
[18] |
L. D. Wood, D. W. Parsons, S. Jones, J. Lin, T. Sjöblom, R. J. Leary, D. Shen, S. M. Boca, T. Barber, J. Ptak, N. Silliman, S. Szabo, Z. Dezso, V. Ustyanksky, T. Nikolskaya, Y. Nikolsky, R. Karchin, P. A. Wilson, J. S. Kaminker, Z. Zhang, R. Croshaw, J. Willis, D. Dawson, M. Shipitsin, J. K Willson, S. Sukumar, K. Polyak, B. H. Park, C. L. Pethiyagoda, P. V. Pant, D. G. Ballinger, A. B. Sparks, J. Hartigan, D. R. Smith, E. Suh, N. Papadopoulos, P. Buckhaults, S. D. Markowitz, G. Parmigiani, K. W. Kinzler, V. E. Velculescu and B. Vogelstein, The genomic landscapes of human breast and colorectal cancers, Science, 318 (2007), 1108-1113. |
[19] |
C. H. Yeang, F. McCormick and A. Levine, Combinatorial patterns of somatic gene mutations in cancer, FASEB J., 22 (2008), 2605-2622. |
[20] |
M. I. Aladjem, S. Pasa, S. Parodi, J. N. Weinstein, Y. Pommier and K. W.Kohn, Molecular interaction maps-a diagrammatic graphical language for bioregulatory networks, Sci STKE., 222 (2004), pe8. |
[21] |
K. W. Kohn, M. I. Aladjem, J. N. Weinstein and Y. Pommier, Molecular interaction maps of bioregulatory networks: A general rubric for systems biology, Mol. Biol. Cell, 17 (2006), 1-13. |
[22] |
K. W. Kohn, M. I. Aladjem, S. Kim, J. N. Weinstein and Y. Pommier, Depicting combinatorial complexity with the molecular interaction map notation, Mol Syst Biol., 2 (2006), 51. |
[23] |
A. Luna, E. I. Karac, M. Sunshine, L. Chang, R. Nussinov, M. I. Aladjem and K. W. Kohn, A formal MIM specification and tools for the common exchange of MIM diagrams: An XML-Based format, an API, and a validation method, BMC Bioinformatics, 12 (2011), 167. |
[24] |
D. Joyner, M. Van Nguyen and N. Cohen, "Algorithmic Graph Theory," Version 0.5 2010 November 30. |
[25] |
a, GLOBOCAN project http://globocan.iarc.fr/. |
[26] |
G. A. Colditz, S. E. Hankinson, D. J. Hunter, W. C. Willett, J. E. Manson, M. J. Stampfer, C. Hennekens, B. Rosner and F. E. Speizer, The use of estrogens and progestins and the risk of breast cancer in postmenopausal women, N Engl J Med., 332 (1995), 1589-1593. |
[27] |
a, COSMIC 2012: Catalogue of somatic mutations in cancer, http://www.sanger.ac.uk/genetics/CGP/cosmic/. |
[28] |
M. Mukherji, L. M. Brill, S. B. Ficarro, G. M. Hampton and P. G. Schultz, A phosphoproteomic analysis of the ErbB2 receptor tyrosine kinase signaling pathways, Biochemistry, 45 (2006), 15529-15540. |
[29] |
N. R. Leslie and C. P. Downes, PTEN function: how normal cells control it and tumour cells lose it, Biochem. J., 382 (2004), 1-11. |
[30] |
E. Tokunaga, E. Oki, Y. Kimura, T. Yamanaka, A. Egashira, K. Nishida, T. Koga, M. Morita, Y. Kakeji and Y. Maehara, Coexistence of the loss of heterozygosity at the PTEN locus and HER2 overexpression enhances the Akt activity thus leading to a negative progesterone receptor expression in breast carcinoma, Breast Cancer Res. Treat., 101 (2007), 249-257. |
[31] |
N. Castagnino, L. Tortolina, A. Balbi, R. Pesenti, R. Montagna, A. Ballestrero, D. Soncini, A. Nencioni and S. Parodi, Dynamic simulations of pathways downstream of ERBB-family, including mutations and treatments: Concordance with experimental results, Current Cancer Drug Targets (CCDT), 10 (2010), 737-757. |
[32] |
B. N. Kholodenko, J. B. Hoek and H. V. Westerhoff, Why cytoplasmic signalling proteins should be recruited to cell membranes, Trends Cell Biol., 10 (2000), 173-178. |
[33] |
J. Wolf, S. Dronov, F. Tobin and I. Goryanin, The impact of the regulatory design on the response of epidermal growth factor receptor-mediated signal transduction towards oncogenic mutations, FEBS J., 274 (2007), 5505-5517. |
[34] |
B. N. Kholodenko, O. V. Demin, G. Moehren and J. B. Hoek, Quantification of short term signaling by the epidermal growth factor receptor, J Biol. Chem., 274 (1999), 30169-30181. |
[35] |
N. I. Markevich, G. Moehren, O. V. Demin, A. Kiyatkin, J. B. Hoek and B. N. Kholodenko, Signal processing at the Ras circuit: what shapes Ras activation patterns?, Syst Biol (Stevenage), 1 2004, 104-113. |
[36] |
A. Kiyatkin, E. Aksamitiene, N. I. Markevich, N. M. Borisov, J. B. Hoek and B. N. Kholodenko, Scaffolding protein Grb2-associated binder 1 sustains epidermal growth factor-induced mitogenic and survival signaling by multiple positive feedback loops, J. Biol. Chem., 281 (2006), 19925-19938. |
[37] |
M. R. Birtwistle, M. Hatakeyama, N. Yumoto, B. A. Ogunnaike, J. B. Hoek and B. N. Kholodenko, Ligand-dependent responses of the ErbB signaling network: experimental and modeling analyses, Mol. Syst. Biol., 3 (2007), e144. |
[38] |
W. W. Chen, B. Schoeberl, P. J. Jasper, M. Niepel, U. B. Nielsen, D. A. Lauffenburger and P. K. Sorger, Input-output behavior of ErbB signaling pathways as revealed by a mass action model trained against dynamic data, Mol. Syst. Biol., 5 (2009), e239. |
[39] |
T. Nakakuki, M. R. Birtwistle, Y. Saeki, N. Yumoto, K. Ide, T. Nagashima, L. Brusch, B. A. Ogunnaike, M. Okada-Hatakeyama and B. N. Kholodenko, Ligand-specific c-Fos expression emerges from the spatiotemporal control of ErbB network dynamics, Cell., 141 (2010), 884-896. |
[40] |
G. Ernst and G. Wanner, "Solving Ordinary Differential Equations II: Stiff and Differential- Algebraic Problems," Springer-Verlag, 1996. |
[41] |
J. J. Tyson, B. Novak, G. G.M. Odell, K. Chen and C. D. Thron, Chemical kinetic theory: understanding cell-cycle regulation, Trends Biochem. Sci., 21 (1996), 89-96. |
[42] |
S. S. Ng, T. Mahmoudi, E. Danenberg, I. Bejaoui, W. de Lau, H. C. Korswagen, M. Schutte and H. Clevers, Phosphatidylinositol 3-kinase signaling does not activate the Wnt cascade, J Biol Chem., 284 (2009), 35308-35313. |
[43] |
D. Voskas, L. S. Ling and J. R. Woodgett, Does GSK-3 provide a shortcut for PI3K activation of Wnt signalling?, F1000 Biol Rep., 2 (2010), 82. |